PFE - Pfizer Surprises With Q4 Profit Despite Muted COVID Products Demand Sticks To 2024 Guidance | Benzinga
Tuesday, Pfizer Inc (NYSE:PFE) reported a Q4 adjusted EPS of $0.10 versus a consensus loss of $(0.22). The company reported fiscal year 2023 adjusted EPS of $1.84, down 72% year-on-year, significantly impacted by one-time events.
The company reported a 41% decline in Q4 sales to $14.25 billion, down from $24.29 billion a year ago, almost in line with the consensus of $14.21 billion.
Fourth-quarter 2023 Comirnaty revenues declined $6.1 billion, or 54% Y/Y, driven by lower U.S. government contracted deliveries following the transition to traditional U.S. commercial market sales ...